FindTrial
Sign In

Clinical outcomes of ultrasound combined fluoroscopy guided chemical lumbar sympathectomy for thromboangiitis obliterans: A retrospective study

Clinical outcomes of ultrasound combined fluoroscopy guided chemical lumbar sympathectomy for thromboangiitis obliterans: A retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053488
Enrollment
Unknown
Registered
2021-11-22
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thromboangiitis obliterans (Buerge's Disease)

Interventions

lumbar sympathectomy group:Nil
revascularization therapy group:Nil

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with Burger disease; 2. Ultrasound combined with X-ray sympathetic ganglionectomy or vascular reconstruction surgery.

Exclusion criteria

Exclusion criteria: Previous treatment on the limb of study side other than conventional medication, such as stem cell therapy, revascularization therapy or lumbar sympathectomy, et al.

Design outcomes

Primary

MeasureTime frame
visual analogue scale(VAS) of pain;—

Secondary

MeasureTime frame
claudication distence;ulcer healing;Routherford Classification;amputation free survival rate;complications of procedure;hospital stays;Hospital costs;—

Countries

China

Contacts

Public ContactFeng Xia

The First Affiliated Hospital of Sun Yat-Sen University

fengxiar@aliyun.com+86 13688877856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026